Roche buyout was a bad deal for employees - Avis employé Grunt Employee Genentech

2,0
16 déc. 2010
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Decent compensation, 4x10 work week, good benefits. Overall very friendly people work here. One of the most casual companies I have ever worked for. Things are changing now, not for the better.

Inconvénients

Some very horrible mid level management. Schmoozers rise rapidly, jumping job levels every 8 to 16 months. Recent news of layofs has everyone on edge. Old Genentech culture of working for the patient has now become a big pharma regime of cost-cutting and lean times. Conviently disguised by current world-wide economic difficulties. Nice try Roche, your profits aren't really suffering.

Découvrez plus d’avis sur Genentech

5,0
27 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Patient-centric company. great culture & benefits

Inconvénients

Not always clear how promotions are awarded.

2,0
19 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

The work is meaningful and overall the company vision aligns with my goals

Inconvénients

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Voir les avis par: Utile|Évaluation|Date|Tout